XML Financial LLC Purchases New Shares in The Clorox Company $CLX

XML Financial LLC purchased a new position in shares of The Clorox Company (NYSE:CLX) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 5,550 shares of the company’s stock, valued at approximately $560,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Center for Financial Planning Inc. bought a new position in shares of Clorox in the third quarter worth about $25,000. Vermillion & White Wealth Management Group LLC bought a new stake in shares of Clorox during the third quarter valued at approximately $25,000. Darwin Wealth Management LLC bought a new stake in shares of Clorox during the second quarter valued at approximately $29,000. Vision Financial Markets LLC grew its stake in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares during the last quarter. Finally, Ameriflex Group Inc. grew its stake in shares of Clorox by 1,436.8% during the third quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE:CLX opened at $94.07 on Monday. The firm’s 50 day simple moving average is $96.95 and its 200 day simple moving average is $105.34. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The company has a market capitalization of $11.37 billion, a price-to-earnings ratio of 15.27, a P/E/G ratio of 0.49 and a beta of 0.56. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 5.61 earnings per share for the current year.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on CLX. Rothschild & Co Redburn set a $117.00 price target on shares of Clorox in a research note on Friday, February 13th. Citigroup decreased their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. BNP Paribas Exane decreased their price target on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. Morgan Stanley decreased their price target on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research note on Friday, May 1st. Finally, Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average target price of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.